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Abstract Objective Using three-dimensional ultrasound (3D-US), we aimed to compare the
tape position and the angle formed by the sling arms in different techniques of mid-
urethral sling insertion for the surgical treatment of stress urinary incontinence, three
years after surgery. In addition, we examined the correlations between the US findings
and the clinical late postoperative results.
Methods A prospective cross-sectional cohort study of 170 patients who underwent
a sling procedure between May 2009 and December 2011 was performed. The final
sample, with US images of sufficient quality, included 26 retropubic slings (tension-free
vaginal tape, TVT), 42 transobturator slings (tension-free vaginal tape-obturator, TVT-
O), and 37 single-incision slings (tension-free vaginal tape-Secur, TVT-S). The images (at
rest, during the Valsalva maneuver, and during pelvic floor contraction) were analyzed
offline by 2 different observers blinded against the surgical and urinary continence
status. Group comparisons were performed using the Student t-test, the chi-squared
and the Kruskal-Wallis tests, and analyses of variance with Tukey multiple comparisons.
Results Differences among the groups were found in themean angle of the tape arms
(TVT ¼ 119.94°, TVT-O ¼ 141.93°, TVT-S ¼ 121.06°; p < 0.001) and in the distance
between the bladder neck and the tape at rest (TVT ¼ 1.65 cm, TVT-O ¼ 1.93 cm, TVT-
S ¼ 1.95 cm; p ¼ 0.010). The global objective cure rate was of 87.8% (TVT ¼ 88.5%,
TVT-O ¼ 90.5%, TVT-S ¼ 83.8%; p ¼ 0.701). The overall subjective cure rate was of
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Introduction
The current standard surgical treatment for stress urinary
incontinence (SUI) involves tension-free mid-urethral sling
(MUS) placement, either using the retropubic or transobtu-
rator approach, which has a reported success rate of up to
80% at the long-term follow-up.1 More recently, single-inci-
sion slings were developed to minimize some of the risks
related toMUSs, such as infection and chronic pain. However,
this technique has not been well-accepted by the medical
community due to the variability in insertion techniques and
the diversity of materials used to ensure the fixation of the
83.8% (TVT ¼ 88.5%, TVT-O ¼ 88.5% and TVT-S ¼ 78.4%; p ¼ 0.514). The slings were
located in the mid-urethra in 85.7% of the patients (TVT ¼ 100%, TVT-O ¼ 73.8%, TVT-
S ¼ 89.2%; p ¼ 0.001), with a more distal location associated with obesity (distal:
66.7% obese; mid-urethra: 34% obese; p ¼ 0.003). Urgency-related symptoms were
observed in 23.8% of the patients (TVT ¼ 30.8%, TVT-O ¼ 21.4%, TVT-S ¼ 21.6%;
p ¼ 0.630).
Conclusions The angle formed by the arms of the sling tape was more obtuse for the
transobturator slings compared with the angles for the retropubic or single-incision
slings. Retropubic slings were more frequently located in the mid-urethra compared
with the other slings, regardless of obesity. However, the analyzed sonographic
measures did not correlate with the urinary symptoms three years after the surgery.
Resumo Objetivo Comparar por meio de ultrassom tridimensional (US-3D) a posição e o
ângulo entre os braços da faixa, em diferentes técnicas de inserção de sling de uretra
média, para tratamento de incontinência urinária de esforço, 3 anos após a cirurgia,
correlacionando os achados ultrassonográficos aos resultados clínicos pós-operatórios.
Métodos Este é um estudo de coorte transversal prospectivo de 170 pacientes que se
submeteram a um procedimento de sling entre maio de 2009 e dezembro de 2011. Foi
possível avaliar as imagens de US em 105 pacientes: 26 com tension-free vaginal tape
(TVT), 42 com tension-free vaginal tape-obturator (TVT-O) e 37 com tension-free vaginal
tape-Secur (TVT-S). As imagens (em repouso, em manobra de Valsalva e em contração
perineal) foram analisadas por dois observadores diferentes, que desconheciam o tipo
de sling utilizado na cirurgia, assim como as queixas da paciente. A análise estatística foi
realizada por meio dos testes t de Student, qui-quadrado, Kruskal-Wallis, e análise de
variância com comparações múltiplas de Tukey.
Resultados As médias dos ângulos entre os braços da faixa foram: TVT ¼ 119,94°,
TVT-O ¼ 141,93°, TVT-S ¼ 121,06° (p < 0,001). As médias das distâncias entre o colo
vesical e a faixa, em repouso, foram: TVT ¼ 1,65 cm, TVT-O ¼ 1,93 cm, TVT-
S ¼ 1,95 cm (p ¼ 0,010). A taxa de cura objetiva dos slings foi de 87,8% (TVT ¼ 88,5%,
TVT-O ¼ 90,5% e TVT-S ¼ 83,8%; p ¼ 0,701). A taxa de cura subjetiva foi de 83,8%
(TVT ¼ 88,5%, TVT-O ¼ 88,5% e TVT-S ¼ 78,4%; p ¼ 0,514). Os slings estavam na
uretra média em 85,7% (TVT ¼ 100%, TVT-O ¼ 73,8% e TVT-S ¼ 89,2%; p ¼ 0,001)
dos pacientes, e a localização mais distal foi associada a obesidade (distal: 66,7%
obesas; uretra média: 34% obesas; p ¼ 0.003). Os sintomas de urgência foram
observados em 23,8% das pacientes (TVT ¼ 30,8%, TVT-O ¼ 21,4%, TVT-S ¼ 21,6%;
p ¼ 0,630). Não houve diferenças significativas quando se comparam os achados
ultrassonográficos e os grupos de pacientes com sintomas de urgência, cura subjetiva e
objetiva.
Conclusão O ângulo formado pelos braços da faixa foi mais obtuso noTVT-O quando
comparado com oTVT ou o TVT-S. Os TVTs foram localizados mais frequentemente na
uretra média quando comparados com os outros dois grupos, mesmo em pacientes
obesas. Entretanto, as medidas ultrassonográficas não tiveram correlação com os
sintomas urinários três anos após a cirurgia.
Palavras-Chave
► incontinência
urinária
► ultrassonografia
► assoalho pélvico
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device, which has interfered with continence success. Thus,
traditional MUSs are considered significantly superior to
mini-slings in terms of cure outcomes.2–4
Although MUS operations are considered safe, complica-
tions such as urinary obstruction and postoperative urgency
may occur. Imaging techniques can provide assistance in the
diagnosis of these complications.5 Ultrasonography (US) is a
widespread toolused toassess theanatomyand functionof the
pelvic floor structures. It is a non-invasive, reproducible, and
technically simplemethod to visualize the lower urinary tract,
particularly theurethra and thebladder, andanendovaginal or
translabial convex probe can be used.6 Moreover, translabial
three-dimensional ultrasound (3D-US) allows good visualiza-
tion of the suburethral polypropylene sling tape in orthogonal
planes (axial, coronal,mid-sagittal), and canbeused toexplain
the pathogenesis of voiding dysfunction following synthetic
sling procedures.7 Thus, US during the postoperative period
has shown an increasing role in the monitoring of surgically
treated patients, especially for complications such as urinary
retention and urinary disorders. However, there are few
studies that correlate the information obtained by 3D-US
and the prognostic and predictive markers of SUI treatment
with synthetic slings.7
Therefore, the present study utilized translabial 3D-US
3 years after surgeries for the cure of SUI to evaluate and
compare the spatial position of the polypropylene sling
tape for 3 different SUI correction techniques: MUS using
the retropubic approach (tension-free vaginal tape, TVT), the
transobturator approach (tension-free vaginal tape-obturator,
TVT-O), and the single-incision sling (tension-free vaginal
tape-Secur, TVT-S). In addition, the relationship between the
3D-US findings and the objective/subjective cure rates and
urgency-relatedsymptomswasexamined.Ourhypothesiswas
that the angle formed by the arms of the tape following TVT
insertion is the most acute, causing more post-operative
urgencies, whereas the angle following TVT-O insertion is
more obtuse and, consequently, results in more failures of
SUI correction. In addition, we expected the TVT-S, which is
not currently on the market, to act similarly to the TVT.
Moreover, we hypothesized that if the tape is located in the
mid-urethra, the better the long-term clinical postoperative
results.
Methods
Subjects
A prospective cross-sectional cohort study of patients who
underwent a sling procedure at the Urogynecology and
Vaginal Surgery Sector of our institution between
May 2009 and December 2011 was performed. All patients
who underwent the surgery during the study period were
invited (via phone) to participate. The inclusion criteria
were: women over 18 years-old who had undergone SUI
treatment with MUS (using the retropubic or transobturator
routes) or a single-incision sling without any concomitant
pelvic floor surgical procedures. In addition, the patient
should have had a preoperative diagnosis of SUI without
detrusor overactivity. The exclusion criteria were as follows:
incomplete medical records relating to surgical hospitaliza-
tion, urinary incontinence previously treated by surgery
with a polypropylene implant, or undergoing new treat-
ments for urinary incontinence during the follow-up period.
Total of 170 patients were eligible to participate in the study
(48 with TVTs, 56 with TVT-Os, and 66 with TVT-Ss). Among
these, 115 accepted the invitation, being thus selected and
placed in each group according to the surgery performed
(TVT: 26; TVT-O: 46; TVT-S: 43). However, 10 evaluated
patients were excluded from the analysis (2 women pre-
sented with 2 synthetic slings at US, and 3D-US images did
not have perfect technical quality in 8 cases), resulting in a
final sample of 105 patients (TVT: 26; TVT-O: 42; TVT-S: 37).
The patient selection process is depicted in ►Fig. 1.
An urodynamic study was performed before the surgery,
and the results of the Valsalva leak point pressure (VLPP,
mean and standard deviation) were 67.64  19.20 cmH2O,
87.57  32.14 cmH2O and 85.14  27.05cmH2O, for the
TVT, TVT-O and TVT-S groups respectively.
A sample power calculation was performed using the
results of a previous publication,7 which involved the evalu-
ation of the angles formed by the arms of the polypropylene
tape in sonographic images at rest and during the Valsalva
maneuver. At rest, the mean values considered in the sample
calculation were 116° and 137°, respectively for the TVT and
TVT-O groups, and the overall standard deviation considered
was 7. During the Valsalva maneuver, the mean values were
130° (TVT) and 140° (TVT-O),with a standarddeviation of 10.
Considering the power of the sample of 80%, 4 patients per
group at rest and 17 patients per group during the Valsalva
maneuver would be necessary. A p-value < 0.05 was consid-
ered statistically significant.
The studywas approved by theNational Ethics in Research
Committee, and the trial was appropriately registered on
www.clinicaltrials.gov (NCT 02406638). All participants pro-
vided written informed consent, and the research was
performed according to the Declaration of Helsinki, as
revised in 2008.
Procedures
The TVT surgery was performed according to the classical
technique,8 using Gynecare TVT (Ethicon Inc., Somerville,
New Jersey, US). The TVT-O procedure was performed
according to the inside-out technique proposed by de Leval,9
using the Gynecare TVT Obturator System (Ethicon Inc.,
Somerville, New Jersey, US). The single-incision sling (TVT-
Secur, Gynecare TVT Secur System, Ethicon Inc., Somerville,
New Jersey, US) was inserted using the “U” insertion tech-
nique.10 The manufacturer discontinued the commercializa-
tion of the TVT-S in 2012.11
Three-dimensional US imaging and a clinical evaluation
were performed between April 2013 and June 2014. The
physical examination involved stress tests, including the
250-ml bladder volume and the 20-minute pad tests.12 In
addition, the quality of lifewas assessed using the King Health
Questionnaire (KHQ),which had been previously validated for
the Portuguese language.13 Objective cure was defined as the
absence of urinary leakage during the stress tests. Subjective
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cure was defined as the absence of self-reported urinary
leakage as indicated by a KHQ symptoms scale score of 0.
Thepresence of urgency-related symptomswas also evaluated
using the KHQ symptoms scale.
Three-dimensional USwas performed after voiding, with the
patient in the lithotomy position, with the hips flexed and
abducted; it was performed at rest, during the Valsalva
maneuver, and during perineal contraction. The 3D-US equip-
ment (Voluson730Expert,GeneralElectric [GE]Healthcare, Zipf,
Austria) included a convex volumetric transducer covered by a
plastic transducer (4–8 Mhz) with an acquisition angle of 85°.
The obtained images of the pelvic floor were later evaluated
using the 4D View (version 14, ext 0; GE Kretz Ultrasound, GE
Healthcare, Zipf, Austria) software on a computer with the
Windows system. For the analysis of the images, the sagittal
plane (two-dimensional [2D] image) was selected with the
sight line through thepubis, the urethra, and thepolypropylene
sling tape.14 The assessors of the ultrasound datawere blinded
against all clinical data. The measurements of the urethral
length (UL) and the distance between the bladder neck and
thecentral pointof the tape (BT)wereperformedusing a2D-US
image in the mid-sagittal plane (►Fig. 2). The tape displace-
ment in relation to the UL was measured as the difference
between the ratio of the BT and UL at rest and during the
Valsalvamaneuver or pelvicfloorcontraction. Foranevaluation
of the relative position of the tape, we divided the BT by the UL,
and the resulting number was used to classify the position of
the tape within the urethra. The tape was considered to be: in
theproximal-third (closest to thebladder neck) if the resultwas
between 0 and 0.33; in the middle-third if the result was
between 0.34 and 0.66; and in the distal-third (closest to the
externalurethralostium) if the resultwasbetween0.67and1.0.
The OmniView volume contrast imaging (VCI) mode
(GE Healthcare, Zipf, Austria) was used during the image
analysis, sliding digitally with a straight line passing through
the lower edge of the pubic symphysis, the urethra, and the
lower tape. In order to improve visibility, VCI was selected,
with a thickness of 3.0 mm,which allowed thevisualization of
the pubis, the urethra, the vagina, the tape, and the rectum
(►Fig. 2).15 TheOmniView-VCImodewas used to evaluate the
angle formed by the tape arms (Ao), as well as the distance
between the posterior inferior symphysis margin and
the echogenic center of the urethra (PU), and the distance
between the echogenic center of the urethra and the tape (UT)
(►Fig. 2). The mobility of the urethra during movement was
calculated as the difference between the PU at rest and the PU
during the Valsalva maneuver or pelvic floor contraction.
Statistical analyses were performed using the Minitab
software (Minitab, Inc., State College, PA, US), version 16.
The Mann-Whitney test was used for the continuous non-
parametric variables, and the Student t-test was used for the
continuous parametric variables. The Chi-squared, Fisher,
Kruskal-Wallis, and Pearson correlation tests were used for
the nominal variables. Analyses of variance (ANOVAs) for
continuous variables were performed using the Tukey
multiple comparison procedure. A p-value < 0.05 was con-
sidered statistically significant.16,17
Results
The three surgical groups (26 TVT, 42 TVT-O, and 37 Minis-
ling TVT-S) were similar in terms of age, body mass index
(BMI), the number of vaginal or caesarean deliveries, and
hormonal status, as shown in ►Table 1. At the time of the
Fig. 1 Patient selection flowchart: the patient selection process is depicted. Abbreviations: TVT, tension-free vaginal tape (retropubic sling);
TVT-O, tension-free vaginal tape-obturator (transobturator sling); TVT-S, tension-free vaginal tape-Secur (single-incision sling).
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evaluation, the postoperative time ranged between 36 and
40 months.
The 2D-US measurements obtained in the mid-sagittal
plane are presented in ►Table 2. The UL at rest, during the
Valsalva maneuver, and during pelvic floor contraction did
not significantly differ among the three groups. In contrast,
there were differences among the groups regarding the BT.
Specifically for the TVT group, the tape was significantly
Fig. 2 Example images: (A) a2D-USmid-sagittalplane (left) and3DOmniViewaxial image (right) imageof thepelvicfloorare shown.Notethe slingposition
(whitehyperechoic structure–T) andurethra (hypoechoic structure–U). Two imagesbelow - OmniViewmode: Theaxial planeon theOmniViewmodewith
pelvic floor organs, at the left (B), and measurements, at the right (C), is shown. Abbreviations: Ao, angle between the two arms of the sling; P, symphysis
pubis; PU, distancebetween thesymphysispubis and theurethra; R, rectum;T, polypropylene tape (sling); U, urethra;UT,distancebetween the tapeand the
urethra; V, vagina.
Table 1 Patient characteristics
TVT (n ¼ 26)
Mean (SD)
TVT-O (n ¼ 42)
Mean (SD)
TVT-S (n ¼ 37)
Mean (SD)
p
Age (Years) 58.35 (9.79) 55.00 (10.77) 54.51 (13.2) 0.384a
BMI (Kg/m2) 27.87 (3.66) 30.41 (5.16) 29.50 (5.35) 0.121a
Caesarean delivery 0.42 (0.86) 0.52 (0.89) 0.62 (0.83) 0.372b
Vaginal delivery 1.89 (1.11) 2.71 (2.11) 3.05 (2.73) 0.130b
Menopause (%) 22 (84.60%) 26 (61.90%) 24 (64.86%) 0.122c
Abbreviations: BMI, body mass index; SD, standard deviation; TVT, tension-free vaginal tape (retropubic sling); TVT-O, tension-free vaginal
tape-obturator (transobturator sling); TVT-S, tension-free vaginal tape-Secur (single-incision sling).
Notes: aANOVA; bKruskal-Wallis test; cChi–squared test. The values are represented as mean and SD (range) and n (%), and are attributed to patients who
underwent surgical treatment for stress urinary incontinence using a retropubic sling (TVT), a transobturator sling (TVT-O), or a single-incision sling (TVT-S).
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closer to the bladder neck compared with the other groups
during rest (p ¼ 0.001), but not during the Valsalva maneu-
ver (p ¼ 0.08) or pelvic floor contraction (p ¼ 0.11). There
was no significant difference in the displacement of the tape
among the three groups.
The location of the sling relative to the urethra was
different among the groups at rest and during movement
(rest: p < 0.001; Valsalva: p ¼ 0.008; pelvic floor contrac-
tion: p < 0.001). Specifically in the TVT group, all tapes
(100%) were located in the mid-urethra during rest and
during movement (Valsalva maneuver and pelvic floor con-
traction). However, for the TVT-O group, only 31 out of 42
tapes (73.8%) were located in the mid-urethra at rest, and for
the TVT-S group, 33 out of 37 tapes (89.2%) were located in
the mid-urethra at rest. Furthermore, during the Valsalva
maneuver, 78.6% of tapes in the TVT-O group and 78.4% in
the TVT-S group were located in the mid-urethra. During
pelvic floor contraction, only 73.8% of the tapes in the TVT-0
group and 86.5% in the TVT-S group were located in the
mid-urethra.
Of the 15 patients with the tape located in the distal
urethra, 66.7% had a BMI > 30 kg/m2 (obese status). In
contrast, of the 90 patients with the tape located in the
mid-urethra, only 34% were obese as assessed by BMI (mid-
urethra versus distal urethra: p ¼ 0.003). The total sample
had 40/105 (38%) obese patients.
The measurements taken using the OmniView-VCI mode
are shown in ►Table 2. The angle formed by the arms of the
sling was not significantly different between the TVT and
TVT-S groups, but was more obtuse in the TVT-O group
compared with the other groups during rest (p < 0.001),
during the Valsalva maneuver (p < 0.001), and during pelvic
floor contraction (p < 0.001). There were no significant
group differences regarding the PU, at rest or during move-
ment. While the UT at rest and during pelvic floor contrac-
tion did not show differences among the groups, during the
Valsalva maneuver, the UT significantly differed among the
groups (p ¼ 0.01), with a smaller UT in the TVT group
compared with the TVT-S group. No significant differences
among the groups regarding urethral mobility during the
Valsalva maneuver and during pelvic floor contraction were
found (p ¼ 0.78 and p ¼ 0.51 respectively).
Information on subjective and objective cure is presented
in ►Table 3. A subjective cure was achieved by 88 of the 105
patients (83.8%), with no difference among the groups
(p ¼ 0.701). An objective cure was verified in 92/105
(87.8%) patients, with no difference among the groups
(p ¼ 0.514). The presence of urgency-related symptoms
Table 2 Midsagittal sonographic and OmniView-VCI mode measurements
TVT (n ¼ 26)
Mean (SD)
TVT-O (n ¼ 42)
Mean (SD)
TVT-S (n ¼ 37)
Mean (SD)
p
Urethral length: rest (cm) 3.34 (0.37) 3.24 (0.40) 3.36 (0.45) 0.38
Urethral length: Valsalva (cm) 3.26 (0.30) 3.18 (0.40) 3.25 (0.42) 0.63
Urethral length: contraction (cm) 3.56 (0.42) 3.34 (0.39) 3.53 (0.49) 0.07
BT: rest (cm) 1.65(0.26) 1.93 (0.38) 1.95 (0.51) 0.01
BT: Valsalva (cm) 1.67 (0.24) 1.85 (0.37) 1.89 (0.50) 0.08
BT: contraction (cm) 1.81 (0.38) 2.03 (0.39) 2.03 (0.57) 0.11
Mid-urethra tape n (%): rest 26 (100%) 31 (73.8%) 33 (89.2%) 0.008
Mid-urethra tape n (%):Valsalva 26 (100%) 33 (78.6%) 29 (78.4%) 0.036
Mid-urethra tape n (%): contraction 26 (100%) 31 (73.8%) 32 (86.5%) 0.013
A°: rest 119.94 (19.66) 141.93 (14. 25) 121.06 (14. 24) < 0.001
A°: Valsalva 130.79 (21.78) 14.,48 (13. 23) 124.40 (24. 79) < 0.001
A°: contraction 120.94 (16.63) 144.77 (16. 51) 126.53 (18. 20) < 0.001
PU: rest (cm) 1.68 (0.28) 1.53 (.,25) 1.64 (0.29) 0.08
PU: Valsalva (cm) 1.72 (0.29) 1.59 (0.28) 1.64 (0.14) 0.19
PU: contraction (cm) 1.65 (0.27) 1.49 (0.29) 1.66 (0.31) 0.02
UT: rest (cm) 0.67 (0.14) 0.73 (0.15) 0.71 (0.11) 0.21
UT: Valsalva (cm) 0.65 (0.13) 0.68 (0.14) 0.75 (0.14) 0.01
UT: contraction (cm) 0.60 (0.01) 0.65 (0.15) 0.66 (0.10) 0.16
Abbreviations: Ao, angle of the two arms of the sling; BT, distance between the bladder neck and the tape; PU, distance between the symphysis pubis
and the urethra; SD, standard deviation; TVT, tension-free vaginal tape (retropubic sling); TVT-O, tension-free vaginal tape-obturator (transobturator
sling); TVT-S, tension-free vaginal tape-secure (single-incision sling); UT, distance between the tape and the urethra.
Notes: ANOVA, Tukey multiple comparisons. The midsagittal sonographic measurements and OmniView-VCI mode measurements of patients who
underwent surgical treatment for stress urinary incontinence using a retropubic sling (TVT), a transobturator sling (TVT-O), or a single-incision sling
(TVT-S) are provided.
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Table 3 Urinary symptoms
TVT TVT-O TVT-S TOTAL p
Subjective cure 23 (88.5%) 36 (85.7%) 29 (78.4%) 88 (83.8%) 0.514a
Objective cure 23 (88.5%) 38 (90.5%) 31 (83.8%) 92 (87.8%) 0.701b
Urgency symptoms 8 (30.8%) 9 (21.4%) 8 (21.6%) 25 (23.8%) 0.630a
TOTAL 26 (100%) 42 (100%) 37 (100%) 105 (100%)
Abbreviations: TVT, tension-free vaginal tape (retropubic sling); TVT-O, tension-free vaginal tape-obturator (transobturator sling); TVT-S, tension-free
vaginal tape-secure (single-incision sling).
Notes: aChi-squared test; bFisher exact test. The subjective and objective cure rates and the rate of urgency-related symptoms for patients who
underwent surgical treatment for stress urinary incontinence using a retropubic sling (TVT), a transobturator sling (TVT-O), or a single-incision sling
(TVT-S) are provided.
Table 4 Associations between ultrasound measurements and urinary symptoms
Subjective cure Objective cure Urgency symptoms
YES NO p YES NO p YES NO p
(n ¼ 88) (n ¼ 17) (n ¼ 92) (n ¼ 13) (n ¼ 25) (n ¼ 25)
M M M M M M
(SD) (SD) (SD) (SD) (SD) (SD)
BT: rest (cm) 1.87 1.86 0.96 1.85 1.98 0.50 1.76 1.76 0.25
(0.38) (0.62) (0.38) (0.66) (0.52) (0.52)
BT: Valsalva (cm) 1.8 1.95 0.29 1.79 2.02 0.24 1.85 1.85 0.74
(0.35) (0.59) (0.35) (0.66) (0.48) (0.48)
BT: contraction (cm) 1.96 2.01 0.80 1.95 2.12 0.37 1.93 1.93 0.60
(0.44) (0.60) (0.43) (0.64) (0.50) (0.50)
Ratio BT/UL: rest 0.57 0.55 0.62 0.56 0.57 0.71 0.53 0.53 0.09
(0.09) (0.12) (0.09) (0.12) (0.11) (0.11)
Ratio BT/UL: Valsalva 0.56 0.57 0.68 0.56 0.58 0.61 0.56 0.56 0.64
(0.09) (0.13) (0.09) (0.14) (0.02) (0.02)
Ratio BT/LU: contraction 0.57 0.57 0.10 0.57 0.58 0.62 0.56 0.56 0.56
(0.09) (0.09) (0.10) (0.10) (0.10) (0.10)
A(o): rest 129.2° 127.9° 0.81 128.3° 133.9° 0.35 128.5° 128.5° 0.89
(18.5) (21.3) (18.8) (19.6) (21.5) (21.5)
A (o): Valsalva 136.6° 133.2° 0.58 135.6° 139.3° 0.94 136.3° 136.3° 0.99
(23.0) (22.6) (23.0) (22.2) (21.4) (21.4)
A (o): contraction 132.4° 132.5° 0.99 131.4° 139.9° 0.26 133.3° 133.3° 0.82
(18.9) (25.2) (19.0) (24.8) (23.2) (23.2)
Urethral mobility:
rest-Valsalva (cm)
-0.03 -0.06 0.73 -0.04 -0.05 0.87 -0.08 -0.08 0.31
(0.24) (0.31) (0.25) (0.31) (0.23) (0.23)
Urethral mobility:
rest-contraction (cm)
0.03 0.04 0.36 0.03 0.03 0.52 0.011 0.011 0.86
(0.21) (0.31) 0.21 (0.32) (0.27) (0.27)
Abbreviations: A, Angle of the two arms of the sling; BT, distance between thebladder neck and tape;M,mean; SD, standard deviation; UL, urethral length.
Notes: Student t-test. The results of the analyses examining the potential associations between sonographic measurements and urinary symptoms
are provided for patients who underwent surgical treatment for stress urinary incontinence using a retropubic sling (TVT), a transobturator sling
(TVT-O) or a single-incision sling (TVT-S).
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was observed in 25/105 (23.8%) patients, with no difference
among the groups (p ¼ 0.630).
Correlations between the tape’s spatial position and the
clinical results are shown in ►Table 4. No significant rela-
tionshipswere found, except for the displacement of the tape
in relation to theUL between rest and contraction,whichwas
slightly greater in the direction of the bladder neck in
patients with urgency-related symptoms compared with
those without symptoms (p ¼ 0.03). No significant differ-
ences among the groups were found for the domains of the
KHQ (►Table 5).
Discussion
Three-dimensional US imaging of the pelvic floor is a non-
invasive and reproducible technique for the evaluation of
postoperative MUS, and it enables a dynamic assessment of
the polypropylene sling tape,with good visibility during rest,
pelvic floor contraction, and the Valsalva maneuver.7
The BT found in the present study is consistent with
previously published data.18,19 In addition, for the majority
of the patients (85.7%), the sling was located in the mid-
urethra, and all other patients had slings located in the distal
urethra (14.3%). These results are also similar to those
obtained by others researchers.19–21 We observed that
66.7% of the patients with the tape located in the distal
urethra had a BMI > 30 kg/m2 (obese status), while among
those with the tape located in the mid-urethra, only 34%
were obese. Thus, obesity appears to be a factor favoring a
more distal position of the sling. However, the tape remained
located in themid-urethra in all individuals in the TVT group,
thus showing a better location in obese patients aswell, three
years after the surgery.
The angle formed by the tape arms was less obtuse in the
TVTandTVT-Sgroupscomparedwith theTVT-Ogroup (at rest,
during the Valsalvamaneuver, and during pelvic floor contrac-
tion), with no differences between the TVT and TVT-S groups.
This finding was as we expected, and it may be explained by
features of the sling insertion technique.7,22 For the TVT-O, the
insertion was in a “hammock” position, while for the TVT and
TVT-S, the insertionwas in a “U”position. The “U”positionwas
considered the best way to insert the TVT-S before its com-
mercialization was discontinued.
It is interesting to note that no differences among the
surgical techniques were identified with regard to tape
displacement or urethra mobility, in rest or during move-
ment, which is as expected, given that the three surgical
procedures are meant to stabilize urethral mobility.
The distance between the urethra and the tape was
smaller in the TVT group compared with the TVT-S group
during the Valsalva maneuver only. This finding could sug-
gest a higher frequency of postoperative urgency-related
symptoms with the TVT. However, similarly to previous
studies, we did not observe any differences between TVT
and TVT-O groups in terms of this sonographic measure.22
Even though no associations between the position of the
MUS tape and the clinical results were found, it was noted
that, in patients with urgency-related symptoms, the tape
tended to move more toward the bladder neck during the
Valsalva maneuver. On the other hand, during pelvic floor
contraction, there was a greater displacement of the tape
toward the bladder neck in patients who reported urgency-
related symptoms compared with patients without these
symptoms. This may be a mechanism that explains the onset
of de novo urgency in the postoperative period.
A lack of correlation between the tape position and the
clinical outcomes has been previously reported6,20,23 and
was confirmed in the present study, suggesting that factors
other than tape position could influence the results of the
insertion of theMUS.23,24 Although some sonographicmeas-
urements reached statistical significance in the group com-
parisons, the differences are on the order of millimeters, and
are not clinically significant.
The limitations of the present study include the cross-
sectional design, with only a midterm postoperative follow-
up. Therefore, wewere not able to compare the preoperative
and postoperative results or evaluate the earlier failures
requiring surgical re-intervention, which could be related
to tape position, as suggested by other studies.24,25However,
our study sample does reproduce the results from the
literature regarding the objective and subjective cure rates
and the frequency of urinary urgency symptoms, according
to the different surgical techniques.1,2
Conclusion
In conclusion, we observed differences in the synthetic sling
position three years after surgery when comparing different
routes of insertion. In the retropubic approach, the tape was
Table 5 Quality of life assessments (King Health Questionnaire)
TVT-R
Mean
TVT-O
Mean
TVT-S
Mean
p
General health 29.81 24.40 25.68 0.28
Incontinence impact 12.82 13.49 13.51 0.92
Limitations to daily
activities
10.26 8.33 13.06 0.67
Limitations to physical
activities
11.54 7.14 11.56 0.56
Social limitations 10.26 3.70 6.01 0.62
Impact on personal
relationships
3.92 3.09 5.36 0.86
Impact on emotions 6.41 9.52 9.31 0.73
Impact on sleep
arrangement
8.97 6.75 5.41 0.58
Severity measure 13.14 10.52 9.01 0.69
Abbreviations: TVT, tension-free vaginal tape (retropubic sling); TVT-O,
tension-free vaginal tape-obturator (transobturator sling); TVT-S,
tension-free vaginal tape-secur (single-incision sling).
Notes: Kruskal Wallis test. Quality of life data as assessed using the King
Health Questionnaire are provided for patients who underwent surgical
treatment for stress urinary incontinence using a retropubic sling (TVT),
a transobturator sling (TVT-O) or a single-incision sling (TVT-S).
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more frequently located in the mid-urethra compared with
the transobturator route and the single-incision sling.
Regarding the angle of the sling arms, it was more obtuse
with the transobturator route, and it was, in a similar
manner, more acute with the retropubic route and
the single-incision sling. Although a relationship between
the position of the MUS tape and the subjective/objective
cure three years after surgery was not demonstrated, there
was a correlation between the movement of the tape during
pelvic floor contraction and the presence of symptoms of
urgency.
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